A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
NCT ID: NCT00215436
Last Updated: 2010-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
345 participants
INTERVENTIONAL
2005-03-31
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Formoterol Fumarate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current or prior history of cigarette smoking
Exclusion Criteria
* Chest X-ray diagnostic of significant disease other than COPD
* Significant condition or disease other than COPD
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dey
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dey L.P.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Jasper, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tuscon, Arizona, United States
Research Site
Buena Park, California, United States
Research Site
Huntington Beach, California, United States
Research Site
Long Beach, California, United States
Research Site
Long Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
San Diego, California, United States
Research Site
Stockton, California, United States
Research Site
Denver, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
Research Site
Hartford, Connecticut, United States
Research Site
Clearwater, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Woodstock, Georgia, United States
Research Site
Hines, Illinois, United States
Research Site
Normal, Illinois, United States
Research Site
Florence, Kentucky, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Rochester, Minnesota, United States
Research Site
Saint Charles, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Butte, Montana, United States
Research Site
Henderson, Nevada, United States
Research Site
Cherry Hill, New Jersey, United States
Research Site
Summit, New Jersey, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Camillus, New York, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Medford, Oregon, United States
Research Site
Portland, Oregon, United States
Research Site
Cranston, Rhode Island, United States
Research Site
Spartanburg, South Carolina, United States
Research Site
Dallas, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Richmond, Virginia, United States
Research Site
Madison, Wisconsin, United States
Research Site
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nelson HS, Gross NJ, Levine B, Kerwin EM, Rinehart M, Denis-Mize K; Formoterol Study Group. Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Oct;29(10):2167-78. doi: 10.1016/j.clinthera.2007.10.007.
Gross NJ, Nelson HS, Lapidus RJ, Dunn L, Lynn L, Rinehart M, Denis-Mize K; Formoterol Study Group. Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. Respir Med. 2008 Feb;102(2):189-97. doi: 10.1016/j.rmed.2007.10.007.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201-065
Identifier Type: -
Identifier Source: org_study_id